159 related articles for article (PubMed ID: 31655798)
1. T5224, RSPO2 and AZD5363 are novel drugs against functional pituitary adenoma.
Zhong S; Wu B; Li J; Wang X; Jiang S; Hu F; Dou G; Zhang Y; Sheng C; Zhao G; Li Y; Chen Y
Aging (Albany NY); 2019 Oct; 11(20):9043-9059. PubMed ID: 31655798
[TBL] [Abstract][Full Text] [Related]
2. Identification of driver genes and key pathways of prolactinoma predicts the therapeutic effect of genipin.
Zhong S; Wu B; Wang X; Sun D; Liu D; Jiang S; Ge J; Zhang Y; Liu X; Zhou X; Jin R; Chen Y
Mol Med Rep; 2019 Sep; 20(3):2712-2724. PubMed ID: 31322266
[TBL] [Abstract][Full Text] [Related]
3. Identification of driver genes and key pathways of non-functional pituitary adenomas predicts the therapeutic effect of STO-609.
Wu B; Jiang S; Wang X; Zhong S; Bi Y; Yi D; Liu G; Hu F; Dou G; Chen Y; Wu Y; Dong J
PLoS One; 2020; 15(10):e0240230. PubMed ID: 33119597
[TBL] [Abstract][Full Text] [Related]
4. Identification of Potential Biomarkers with Diagnostic Value in Pituitary Adenomas Using Prediction Analysis for Microarrays Method.
Peng H; Deng Y; Wang L; Cheng Y; Xu Y; Liao J; Wu H
J Mol Neurosci; 2019 Nov; 69(3):399-410. PubMed ID: 31280474
[TBL] [Abstract][Full Text] [Related]
5. Selected using bioinformatics and molecular docking analyses, PHA-793887 is effective against osteosarcoma.
Wu B; Yang W; Fu Z; Xie H; Guo Z; Liu D; Ge J; Zhong S; Liu L; Liu J; Zhu D
Aging (Albany NY); 2021 Jun; 13(12):16425-16444. PubMed ID: 34156352
[TBL] [Abstract][Full Text] [Related]
6. Identification of differentially expressed genes in pituitary adenomas by integrating analysis of microarray data.
Zhao P; Hu W; Wang H; Yu S; Li C; Bai J; Gui S; Zhang Y
Int J Endocrinol; 2015; 2015():164087. PubMed ID: 25642247
[TBL] [Abstract][Full Text] [Related]
7. Novel Biomarkers for Non-functioning Invasive Pituitary Adenomas were Identified by Using Analysis of microRNAs Expression Profile.
Wu S; Gu Y; Huang Y; Wong TC; Ding H; Liu T; Zhang Y; Zhang X
Biochem Genet; 2017 Jun; 55(3):253-267. PubMed ID: 28315020
[TBL] [Abstract][Full Text] [Related]
8. Computational analysis identifies invasion-associated genes in pituitary adenomas.
Cao C; Wang W; Ma C; Jiang P
Mol Med Rep; 2015 Aug; 12(2):1977-82. PubMed ID: 25824863
[TBL] [Abstract][Full Text] [Related]
9. Identification of Important Invasion-Related Genes in Non-functional Pituitary Adenomas.
Joshi H; Vastrad B; Vastrad C
J Mol Neurosci; 2019 Aug; 68(4):565-589. PubMed ID: 30982163
[TBL] [Abstract][Full Text] [Related]
10. IGF1 induces cell proliferation in human pituitary tumors - functional blockade of IGF1 receptor as a novel therapeutic approach in non-functioning tumors.
Rubinfeld H; Kammer A; Cohen O; Gorshtein A; Cohen ZR; Hadani M; Werner H; Shimon I
Mol Cell Endocrinol; 2014 Jun; 390(1-2):93-101. PubMed ID: 24769281
[TBL] [Abstract][Full Text] [Related]
11. Co-treatment of Salinomycin Sensitizes AZD5363-treated Cancer Cells Through Increased Apoptosis.
Choi AR; Jung MJ; Kim JH; Yoon S
Anticancer Res; 2015 Sep; 35(9):4741-7. PubMed ID: 26254364
[TBL] [Abstract][Full Text] [Related]
12. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
[TBL] [Abstract][Full Text] [Related]
13. AKT Antagonist AZD5363 Influences Estrogen Receptor Function in Endocrine-Resistant Breast Cancer and Synergizes with Fulvestrant (ICI182780) In Vivo.
Ribas R; Pancholi S; Guest SK; Marangoni E; Gao Q; Thuleau A; Simigdala N; Polanska UM; Campbell H; Rani A; Liccardi G; Johnston S; Davies BR; Dowsett M; Martin LA
Mol Cancer Ther; 2015 Sep; 14(9):2035-48. PubMed ID: 26116361
[TBL] [Abstract][Full Text] [Related]
14. Identifying the key genes and microRNAs in colorectal cancer liver metastasis by bioinformatics analysis and in vitro experiments.
Zhang T; Guo J; Gu J; Wang Z; Wang G; Li H; Wang J
Oncol Rep; 2019 Jan; 41(1):279-291. PubMed ID: 30542696
[TBL] [Abstract][Full Text] [Related]
15. Pituitary tumor transforming gene and insulin-like growth factor 1 receptor expression and immunohistochemical measurement of Ki-67 as potential prognostic markers of pituitary tumors aggressiveness.
Sánchez-Tejada L; Sánchez-Ortiga R; Moreno-Pérez O; Montañana CF; Niveiro M; Tritos NA; Alfonso AM
Endocrinol Nutr; 2013; 60(7):358-67. PubMed ID: 23416216
[TBL] [Abstract][Full Text] [Related]
16. Differential gene expression in pituitary adenomas by oligonucleotide array analysis.
Morris DG; Musat M; Czirják S; Hanzély Z; Lillington DM; Korbonits M; Grossman AB
Eur J Endocrinol; 2005 Jul; 153(1):143-51. PubMed ID: 15994756
[TBL] [Abstract][Full Text] [Related]
17. Analysis of differential gene expression using fiber-optic bead array and pathway analyses in pituitary adenomas.
Jiang Z; Gui S; Zhang Y
J Clin Neurosci; 2011 Oct; 18(10):1386-91. PubMed ID: 21802306
[TBL] [Abstract][Full Text] [Related]
18. Gene module analysis of juvenile myelomonocytic leukemia and screening of anticancer drugs.
Zhao W; Wang L; Yu Y
Oncol Rep; 2018 Dec; 40(6):3155-3170. PubMed ID: 30272300
[TBL] [Abstract][Full Text] [Related]
19. Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis.
Li Y; Li L
J Ovarian Res; 2019 Nov; 12(1):106. PubMed ID: 31703725
[TBL] [Abstract][Full Text] [Related]
20. Identification of candidate target genes of pituitary adenomas based on the DNA microarray.
Zhou W; Ma CX; Xing YZ; Yan ZY
Mol Med Rep; 2016 Mar; 13(3):2182-6. PubMed ID: 26782791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
